共 94 条
[3]
ORAL PROTEIN KINASE C β INHIBITION USING RUBOXISTAURIN Efficacy, Safety, and Causes of Vision Loss Among 813 Patients (1,392 Eyes) with Diabetic Retinopathy in the Protein Kinase C β Inhibitor-Diabetic Retinopathy Study and the Protein kinase C β Inhibitor-Diabetic Retinopathy Study 2
[J].
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES,
2011, 31 (10)
:2084-2094
[5]
[7]

